BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18418656)

  • 1. Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer.
    Caudle AS; Kim HJ; Tepper JE; O'Neil BH; Lange LA; Goldberg RM; Bernard SA; Calvo BF; Meyers MO
    Ann Surg Oncol; 2008 Jul; 15(7):1931-6. PubMed ID: 18418656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
    Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy comparison of neoadjuvant radiotherapy with or without chemotherapy for locally advanced rectal cancer].
    Wu B; Qiu HZ; Xiao Y; Lin GL; Niu BZ; Zhang FQ; Hu K
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):124-7. PubMed ID: 18344077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
    Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M
    Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does diabetes mellitus influence pathologic complete response and tumor downstaging after neoadjuvant chemoradiation for esophageal and gastroesophageal cancer? A two-institution report.
    Showalter SL; Rosato EL; Anne PR; Scott W; Mitchell E; Berger AC
    J Surg Oncol; 2010 Jan; 101(1):43-6. PubMed ID: 19798684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer.
    Pucciarelli S; Capirci C; Emanuele U; Toppan P; Friso ML; Pennelli GM; Crepaldi G; Pasetto L; Nitti D; Lise M
    Ann Surg Oncol; 2005 Feb; 12(2):111-6. PubMed ID: 15827790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant therapy for rectal cancer: improved tumor response, local recurrence, and overall survival in nonanemic patients.
    Box B; Lindsey I; Wheeler JM; Warren BF; Cunningham C; George BD; Mortensen NJ; Jones AC
    Dis Colon Rectum; 2005 Jun; 48(6):1153-60. PubMed ID: 15868236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of clinical outcomes and prognostic factors of neoadjuvant chemoradiotherapy combined with surgery: intraperitoneal versus extraperitoneal rectal cancer.
    Benzoni E; Terrosu G; Bresadola V; Cerato F; Cojutti A; Milan E; Dado G; Bresadola F
    Eur J Cancer Care (Engl); 2006 Jul; 15(3):286-92. PubMed ID: 16882126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer.
    Perez RO; São Julião GP; Habr-Gama A; Kiss D; Proscurshim I; Campos FG; Gama-Rodrigues JJ; Cecconello I
    Dis Colon Rectum; 2009 Jun; 52(6):1137-43. PubMed ID: 19581858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative chemoradiotherapy in locally advanced rectal cancer: Ramathibodi experience.
    Sirachainan E; Sumboonnanonda K; Dangprasert S; Panvichian R; Sirisinha T; Dhanachai M; Pairachvet V; Kraiphibul P; Ratanatharathorn V
    J Med Assoc Thai; 2005 Feb; 88(2):162-7. PubMed ID: 15962665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
    Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
    Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.
    Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Wolff RA; Eng C; Krishnan S; Janjan NA; Crane CH
    Cancer; 2007 May; 109(9):1750-5. PubMed ID: 17387743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer.
    Min BS; Choi YJ; Pyo HR; Kim H; Seong J; Chung HC; Rha SY; Kim NK
    Arch Surg; 2008 Nov; 143(11):1091-7; discussion 1097. PubMed ID: 19015468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Kim SH; Lee JM; Park HS; Eun HW; Han JK; Choi BI
    J Magn Reson Imaging; 2009 May; 29(5):1093-101. PubMed ID: 19388124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer.
    Suppiah A; Hunter IA; Cowley J; Garimella V; Cast J; Hartley JE; Monson JR
    Colorectal Dis; 2009 Mar; 11(3):249-53. PubMed ID: 18513192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
    Suárez J; Vera R; Balén E; Gómez M; Arias F; Lera JM; Herrera J; Zazpe C
    Colorectal Dis; 2008 Jul; 10(6):563-8. PubMed ID: 18070184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer.
    Maretto I; Pomerri F; Pucciarelli S; Mescoli C; Belluco E; Burzi S; Rugge M; Muzzio PC; Nitti D
    Ann Surg Oncol; 2007 Feb; 14(2):455-61. PubMed ID: 17139456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
    Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
    Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.